186664-09-5

Basic information

• Product Name: (3aS,4S,6S,7aS)-4-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-(4-methoxy-phenoxy)-ethyl]-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one
• Synonyms: (3aS,4S,6S,7aS)-4-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-(4-methoxy-phenoxy)-ethyl]-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one
• CAS NO: 186664-09-5
• Molecular Weight: 576.762
• Mol File: 186664-09-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3aS,4S,6S,7aS)-4-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-(4-methoxy-phenoxy)-ethyl]-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (3aS,4S,6S,7aS)-4-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-(4-methoxy-phenoxy)-ethyl]-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one(186664-09-5)
• EPA Substance Registry System: (3aS,4S,6S,7aS)-4-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-(4-methoxy-phenoxy)-ethyl]-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one(186664-09-5)

Safety Data

• Hazardous Substances Data: 186664-09-5(Hazardous Substances Data)

Upstream product

• 186664-07-3 (3aR,4S,6S,7S,7aR)-4-[(S)-1-Hydroxy-2-(4-methoxy-phenoxy)-ethyl]-7-iodo-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one 
• 186664-06-2 2-{(2S,3S,6S)-2-[(S)-1-Hydroxy-2-(4-methoxy-phenoxy)-ethyl]-6-methoxy-3,6-dihydro-2H-pyran-3-yl}-N,N-dimethyl-acetamide 
• 186664-08-4 (3aR,4S,6S,7S,7aR)-4-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-(4-methoxy-phenoxy)-ethyl]-7-iodo-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one 

Downstream Products

• 186664-12-0 (3aS,4S,6S,7aS)-4-[(E)-(S)-1-(tert-Butyl-diphenyl-silanyloxy)-oct-2-enyl]-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one 
• 186664-11-9 (R)-(tert-Butyl-diphenyl-silanyloxy)-((3aS,4S,6S,7aS)-6-methoxy-2-oxo-hexahydro-furo[3,2-c]pyran-4-yl)-acetaldehyde 
• 54397-85-2 thromboxane B₂ 
• 186664-10-8 (3aS,4S,6S,7aS)-4-[(S)-1-(tert-Butyl-diphenyl-silanyloxy)-2-hydroxy-ethyl]-6-methoxy-tetrahydro-furo[3,2-c]pyran-2-one 

Relevant articles and documents

Total synthesis of thromboxane B2 starting from (R,R)-tartaric acid as a chiral pool

Optically active natural thromboxane B2 (TXB2) was synthesized from (R,R)-tartaric acid as only chiral source. The synthesis was achieved through regio- and stereoselective introduction of acetate moiety at the C2-position of the 6,8-dioxabicyclo[3.2.1]octene derivative (2) to provide an acetamide derivative (6), partial ring opening of 6 to give a pyranoid (10), and construction of the C15-hydroxyl group of TXB2 by stereospecific allylic transposition of the inherent chirality of tartaric acid in the transallylic acetate (18).